When it comes to rare immune-mediated conditions, we serve individuals with these diseases and the physicians who treat them by providing therapies and services that can be tailored to each person’s unique needs - even as these needs change across the patient journey.
While each disease is different, the expectations of the individuals who live with them are similar. Takeda’s strength in immunology is built on deep expertise in delivering complex therapies for a variety of conditions.
We aim to provide intelligent, adaptable treatments that help manage and prevent serious conditions, supported by services that assist these individuals in finding the best therapy for their individual case, and adjusting the approach as their needs change.
We support patients with immune-mediated conditions including:
Hereditary angioedema (HAE)
Hereditary angioedema (HAE) is a rare disease that causes unexpected edema (swelling) in various parts of the face and of the body including extremities, the gastrointestinal tract, and upper airways. Depending on the severity of the disease, some people may have multiple attacks each month, while others will go several months without an attack. Attacks often prevent patients to perform their daily activities like going to school or to work. Moreover, attacks occurring in the upper airways area may become life-threatening. This condition occurs in about 1 in 10 000 to 1 in 50 000 people.
What is HAE? - HAE International (HAEi), https://haei.org/hae/ Accessed January 24, 2022.